Cargando…

Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China

In 2002, China integrated hepatitis B vaccine (HepB) into its Expanded Program on Immunization (EPI) using HepB vaccine containing 5 µg of antigen. Although not recommended nationally, there was a common clinical practice in China of screening children for anti-HBs antibody level and giving a booste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Ning, Zheng, Hui, Sun, Xiaojin, Zhang, Guomin, Wang, Fuzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584599/ https://www.ncbi.nlm.nih.gov/pubmed/33097788 http://dx.doi.org/10.1038/s41598-020-75338-5

Ejemplares similares

Hepatitis B vaccination coverage among health care workers in China
por: Yuan, Qianli, et al.
Publicado: (2019)

Acute Hepatitis B — China, 2005−2019
por: Miao, Ning, et al.
Publicado: (2020)

Progress Towards Hepatitis A Control and Prevention Through 2019: the National Immunization Program of China
por: Sun, Xiaojin, et al.
Publicado: (2020)

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination
por: Zhao, Yu-Liang, et al.
Publicado: (2019)

COVID-19 Vaccines’ Protection Over Time and the Need for Booster Doses; a Systematic Review
por: Dadras, Omid, et al.
Publicado: (2022)

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
por: Cui, Fuqiang, et al.
Publicado: (2017)

Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
por: Abdollahi, Alireza, et al.
Publicado: (2022)

Booster Covid Vaccination- Luxury or Need?
por: Karn, Mitesh, et al.
Publicado: (2021)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China
por: Zheng, Hui, et al.
Publicado: (2019)

Enhanced sentinel surveillance for hepatitis B infection in 200 counties in China, 2013-2016
por: Miao, Ning, et al.
Publicado: (2019)

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
por: Feng, Shuo, et al.
Publicado: (2023)

Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose
por: Mendy, Maimuna, et al.
Publicado: (2013)

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
por: Launay, Odile, et al.
Publicado: (2022)

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
por: Ramos, Mafalda, et al.
Publicado: (2016)

The necessity of booster vaccination after neonatal hepatitis B vaccination
por: Lankarani, Kamran Bagheri
Publicado: (2011)

COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose
por: Bruce, Michael G., et al.
Publicado: (2022)

Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination
por: Chan, Paul K. S., et al.
Publicado: (2014)

Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)

Efficacy of Double Dose Recombinant Hepatitis B Vaccination in Chronic Hepatitis C Patients, Compared to Standard Dose Vaccination
por: Minakari, Mohammad, et al.
Publicado: (2014)

Folate Status of Reproductive Age Women and Neural Tube Defect Risk: The Effect of Long-Term Folic Acid Supplementation at Doses of 140 µg and 400 µg per Day
por: Hursthouse, Nicola A., et al.
Publicado: (2011)

Severe pertussis in a young infant due to household transmission: the needs of pertussis vaccination boosters in Japan
por: Takajo, Daiji, et al.
Publicado: (2018)

Is hepatitis B birth dose vaccine needed in Africa?
por: Tamandjou, Cynthia Raissa, et al.
Publicado: (2017)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

Interim statement on covid-19 vaccine booster doses
Publicado: (2021)

Myopericarditis After COVID-19 Booster Dose Vaccination
por: Sharff, Katie A., et al.
Publicado: (2022)

Interim statement on covid-19 vaccine booster doses
Publicado: (2021)

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains
por: Xiao, Chanchan, et al.
Publicado: (2022)

Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine
por: Lu, I-Cheng, et al.
Publicado: (2016)

Long-term immunogenicity of hepatitis B vaccine and impact of a booster dose on health care
por: Bijani, Behzad, et al.
Publicado: (2019)

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
por: Zhou, Hui Jun, et al.
Publicado: (2022)

COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents
por: Canaday, David H., et al.
Publicado: (2022)

Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L
por: Rosario, Pedro Weslley, et al.
Publicado: (2017)

Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood
por: Coppeta, Luca, et al.
Publicado: (2023)

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants
por: Lei, Donna, et al.
Publicado: (2022)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Rzymski, Piotr, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_icimo81vvlnl8qdq5mt59s4k0i